Literature DB >> 25136070

ACVR1 mutations in DIPG: lessons learned from FOP.

Kathryn R Taylor1, Maria Vinci1, Alex N Bullock2, Chris Jones3.   

Abstract

Whole-genome sequencing studies have recently identified a quarter of cases of the rare childhood brainstem tumor diffuse intrinsic pontine glioma to harbor somatic mutations in ACVR1. This gene encodes the type I bone morphogenic protein receptor ALK2, with the residues affected identical to those that, when mutated in the germline, give rise to the congenital malformation syndrome fibrodysplasia ossificans progressiva (FOP), resulting in the transformation of soft tissue into bone. This unexpected link points toward the importance of developmental biology processes in tumorigenesis and provides an extensive experience in mechanistic understanding and drug development hard-won by FOP researchers to pediatric neurooncology. Here, we review the literature in both fields and identify potential areas for collaboration and rapid advancement for patients of both diseases. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25136070      PMCID: PMC4154859          DOI: 10.1158/0008-5472.CAN-14-1298

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

Review 1.  Paediatric and adult malignant glioma: close relatives or distant cousins?

Authors:  Chris Jones; Lara Perryman; Darren Hargrave
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

2.  Substance P signaling mediates BMP-dependent heterotopic ossification.

Authors:  Lixin Kan; Vitali Y Lounev; Robert J Pignolo; Lishu Duan; Yijie Liu; Stuart R Stock; Tammy L McGuire; Bao Lu; Norma P Gerard; Eileen M Shore; Frederick S Kaplan; John A Kessler
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

Review 3.  The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation.

Authors:  Allison M Bond; Oneil G Bhalala; John A Kessler
Journal:  Dev Neurobiol       Date:  2012-07       Impact factor: 3.964

4.  Neurological symptoms in individuals with fibrodysplasia ossificans progressiva.

Authors:  Joseph A Kitterman; Jonathan B Strober; Lixin Kan; David M Rocke; Amanda Cali; Jeannie Peeper; Jennifer Snow; Patricia L R Delai; Rolf Morhart; Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

5.  Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.

Authors:  Peter W Lewis; Manuel M Müller; Matthew S Koletsky; Francisco Cordero; Shu Lin; Laura A Banaszynski; Benjamin A Garcia; Tom W Muir; Oren J Becher; C David Allis
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

Review 6.  TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.

Authors:  Bernhard Schmierer; Caroline S Hill
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

7.  Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development.

Authors:  Y Furuta; D W Piston; B L Hogan
Journal:  Development       Date:  1997-06       Impact factor: 6.868

8.  Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.

Authors:  Gang Wu; Alberto Broniscer; Troy A McEachron; Charles Lu; Barbara S Paugh; Jared Becksfort; Chunxu Qu; Li Ding; Robert Huether; Matthew Parker; Junyuan Zhang; Amar Gajjar; Michael A Dyer; Charles G Mullighan; Richard J Gilbertson; Elaine R Mardis; Richard K Wilson; James R Downing; David W Ellison; Jinghui Zhang; Suzanne J Baker
Journal:  Nat Genet       Date:  2012-01-29       Impact factor: 38.330

9.  A new class of small molecule inhibitor of BMP signaling.

Authors:  Caroline E Sanvitale; Georgina Kerr; Apirat Chaikuad; Marie-Christine Ramel; Agustin H Mohedas; Sabine Reichert; You Wang; James T Triffitt; Gregory D Cuny; Paul B Yu; Caroline S Hill; Alex N Bullock
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

10.  Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma.

Authors:  Kathryn R Taylor; Alan Mackay; Nathalène Truffaux; Yaron Butterfield; Olena Morozova; Cathy Philippe; David Castel; Catherine S Grasso; Maria Vinci; Diana Carvalho; Angel M Carcaboso; Carmen de Torres; Ofelia Cruz; Jaume Mora; Natacha Entz-Werle; Wendy J Ingram; Michelle Monje; Darren Hargrave; Alex N Bullock; Stéphanie Puget; Stephen Yip; Chris Jones; Jacques Grill
Journal:  Nat Genet       Date:  2014-04-06       Impact factor: 38.330

View more
  37 in total

Review 1.  Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease.

Authors:  Flor M Mendez; Felipe J Núñez; Maria B Garcia-Fabiani; Santiago Haase; Stephen Carney; Jessica C Gauss; Oren J Becher; Pedro R Lowenstein; Maria G Castro
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

Review 2.  Developmental origins and oncogenic pathways in malignant brain tumors.

Authors:  Q Richard Lu; Lily Qian; Xianyao Zhou
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-04-03       Impact factor: 5.814

3.  Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases.

Authors:  Harry J Han; Payal Jain; Adam C Resnick
Journal:  Bone       Date:  2017-08-02       Impact factor: 4.398

Review 4.  Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.

Authors:  Tammy Hennika; Oren J Becher
Journal:  J Child Neurol       Date:  2015-09-14       Impact factor: 1.987

5.  Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients.

Authors:  Frederick S Kaplan; Joyce A Kobori; Carmen Orellana; Inmaculada Calvo; Monica Rosello; Francisco Martinez; Berta Lopez; Meiqi Xu; Robert J Pignolo; Eileen M Shore; Jay C Groppe
Journal:  Am J Med Genet A       Date:  2015-06-11       Impact factor: 2.802

6.  Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features.

Authors:  Raphaël Calmon; Volodia Dangouloff-Ros; Pascale Varlet; Christophe Deroulers; Cathy Philippe; Marie-Anne Debily; David Castel; Kevin Beccaria; Thomas Blauwblomme; David Grevent; Raphael Levy; Charles-Joris Roux; Yvonne Purcell; Ana Saitovitch; Monica Zilbovicius; Christelle Dufour; Stéphanie Puget; Jacques Grill; Nathalie Boddaert
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

7.  High-throughput screens for agonists of bone morphogenetic protein (BMP) signaling identify potent benzoxazole compounds.

Authors:  Shayna T J Bradford; Egon J Ranghini; Edward Grimley; Pil H Lee; Gregory R Dressler
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

8.  Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma.

Authors:  Flor Mendez; Padma Kadiyala; Felipe J Nunez; Stephen Carney; Fernando M Nunez; Jessica C Gauss; Ramya Ravindran; Sheeba Pawar; Marta Edwards; Maria Belen Garcia-Fabiani; Santiago Haase; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2020-04-24       Impact factor: 12.531

9.  Leveraging Open Science Drug Development for PET: Preliminary Neuroimaging of 11C-Labeled ALK2 Inhibitors.

Authors:  Emily Murrell; Junchao Tong; David Smil; Taira Kiyota; Ahmed M Aman; Methvin B Isaac; Iain D G Watson; Neil Vasdev
Journal:  ACS Med Chem Lett       Date:  2021-04-23       Impact factor: 4.345

10.  Pathogenic ACVR1R206H activation by Activin A-induced receptor clustering and autophosphorylation.

Authors:  Anassuya Ramachandran; Merima Mehić; Laabiah Wasim; Dessislava Malinova; Ilaria Gori; Beata K Blaszczyk; Diana M Carvalho; Eileen M Shore; Chris Jones; Marko Hyvönen; Pavel Tolar; Caroline S Hill
Journal:  EMBO J       Date:  2021-05-18       Impact factor: 14.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.